Berrien-Elliott Melissa - Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 134 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid Tumors

Anthony El-Khoueiry,Omar Saavedra, Jacob Thomas, Claire Livings,Elena Garralda,Gabriele Hintzen,Laura Kohlhas, Dessislava Vanosmael,Joachim Koch,Erich Rajkovic,Paulien Ravenstijn,Paolo Nuciforo,Todd A Fehniger,Mark Foster,Melissa M Berrien-Elliott,Susanne Wingert, Sina Stäble,Daniela Morales-Espinosa, Delcia Rivas,Michael Emig,Juanita Lopez

Clinical cancer research an official journal of the American Association for Cancer Research（2025）

Cited0Views0WOSBibtex

Memory-like NK Cell Differentiation, Inhibitory NKG2A Blockade, and Improved Recognition Via Antibody or CAR Engineering Combine to Enhance NK Cell Attack Against Multiple Myeloma

Alice Y Zhou,Nancy D Marin, Sadia Afrin,Pamela Wong,Jennifer Tran,Miriam T Jacobs,Michelle Becker-Hapak,Lynne Marsala,Mark Foster,Jennifer A Foltz,Carly C Neal,David A Russler-Germain, Lyra Morina, Yeeun Paik,Celia C Cubitt,Timothy Schappe,Patrick Pence,Ethan McClain,Sarah Kelley, Julie Fortier, Mark Fiala,Michael Slade, Mark Schroeder,Keith Stockerl-Goldstein,Ravi Vij,Feng Gao,Melissa M Berrien-Elliott,Todd A Fehniger

Journal of immunology (Baltimore, Md 1950)no. 1 (2025): 1-11

Cited0Views0WOSBibtex

W-NK1 Choreographs Innate and Adaptive Immune Responses to Provide a Robust and Durable Anti-AML Response

Tom Leedom, Basia Muz,Kristann Magee,Jayakumar Vadakekolathu,Laura Arthur, Melissa Tran,Lena Luukkonen,Nitin Mahajan,Alexander Hamil,John Muth,Melissa M Berrien-Elliott,Todd A Fehniger,Sergio Rutella,Jan K Davidson-Moncada

Bloodno. Supplement 1 (2024): 916-916

Cited0Views0Bibtex

A “prime and Expand” Strategy Using the Multifunctional Fusion Proteins to Generate Memory-Like NK Cells for Cell Therapy

Cancer Immunology Immunotherapyno. 9 (2024)

Cited0Views0WOSBibtex

WUN101-01: First in Human Human (FIH) Phase 1 Study of WU-NK-101 (W-NK1) in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Amanda F. Cashen, MHD Monzr M. Al Malki,Don A. Stevens,Lori Muffly,Natasha Edwin,Edward Abadir,Peter Tan, Sandrine Niyongere,Ashish Bajel,Laura Arthur,Nitin Mahajan, Ben Capoccia,Tom Leedom, Basia Muz,Kristann Magee,Ouiam Bakkacha, Justo L. Gonzalez, Deborah Masters, Stephen Moran,Eileen McNulty,Angela Pannunzio,Jayakumar Vadakekolathu, Tony Wu, Maria del Rosario, Preeta Dasgupta, Michael Munroe, Laura Simpson,Melissa M Berrien-Elliott,John Muth,Sergio Rutella,Jan K Davidson-Moncada,Todd A Fehniger

Bloodno. Supplement 1 (2024): 4257-4257

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn